Abstract
The prescribing of low-dose antipsychotics for challenging behaviour for people with dementia gained prominence following media attention and the publication of the Banerjee report in 2006[1]. The report identified that there are an estimated 180,000 people with dementia on antipsychotic drugs. However, in only about one-third of cases were the drugs beneficial. There were 1,800 […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
